Medeon Biodesign Balance Sheet Health
Financial Health criteria checks 6/6
Medeon Biodesign has a total shareholder equity of NT$2.4B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$2.7B and NT$375.7M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$2.14b |
Equity | NT$2.37b |
Total liabilities | NT$375.65m |
Total assets | NT$2.75b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6499's short term assets (NT$2.2B) exceed its short term liabilities (NT$221.8M).
Long Term Liabilities: 6499's short term assets (NT$2.2B) exceed its long term liabilities (NT$153.9M).
Debt to Equity History and Analysis
Debt Level: 6499 is debt free.
Reducing Debt: 6499 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6499 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6499 has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 35.1% each year.